Compare ARCT & FMAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ARCT | FMAC |
|---|---|---|
| Founded | 2013 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Blank Checks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 163.4M | 159.2M |
| IPO Year | 2019 | 2025 |
| Metric | ARCT | FMAC |
|---|---|---|
| Price | $14.41 | $10.09 |
| Analyst Decision | Buy | |
| Analyst Count | 10 | 0 |
| Target Price | ★ $24.11 | N/A |
| AVG Volume (30 Days) | ★ 1.1M | 62.9K |
| Earning Date | 05-07-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 20.00 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $82,031,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $12.77 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $5.50 | $9.95 |
| 52 Week High | $24.14 | $10.09 |
| Indicator | ARCT | FMAC |
|---|---|---|
| Relative Strength Index (RSI) | 51.75 | 61.61 |
| Support Level | $6.47 | $10.01 |
| Resistance Level | $17.75 | N/A |
| Average True Range (ATR) | 1.37 | 0.01 |
| MACD | -0.39 | 0.00 |
| Stochastic Oscillator | 20.66 | 99.88 |
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on the development of infectious disease vaccines and opportunities within liver and respiratory rare diseases. It operates in one business segment, which includes all activities related to the discovery, development, and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC and LUNAR-CF. Its Vaccine candidates include LUNAR-FLU, KOSTAIVE XBB.1.5, KOSTAIVE, and Others.
Future Money Acquisition Corp is a blank check company formed for the purpose of entering into a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or similar business combination with one or more businesses or entities.